

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 5.98596467 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 4.66684618 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 4.54556369 |
| 4 | negative regulation of heart rate (GO:0010459) | 4.09720982 |
| 5 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.75256676 |
| 6 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.74221850 |
| 7 | dopamine transport (GO:0015872) | 3.72838100 |
| 8 | negative regulation of protein localization to cell surface (GO:2000009) | 3.68057570 |
| 9 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.61538442 |
| 10 | negative regulation of appetite (GO:0032099) | 3.61460045 |
| 11 | negative regulation of response to food (GO:0032096) | 3.61460045 |
| 12 | positive regulation of protein homodimerization activity (GO:0090073) | 3.46968066 |
| 13 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.45469215 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.43223766 |
| 15 | adenosine metabolic process (GO:0046085) | 3.42789408 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.37995034 |
| 17 | regulation of platelet aggregation (GO:0090330) | 3.35590118 |
| 18 | regulation of platelet activation (GO:0010543) | 3.31604431 |
| 19 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.30402338 |
| 20 | platelet dense granule organization (GO:0060155) | 3.29366866 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.27696164 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.27551266 |
| 23 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.24732240 |
| 24 | regulation of memory T cell differentiation (GO:0043380) | 3.24223245 |
| 25 | behavioral response to nicotine (GO:0035095) | 3.23621822 |
| 26 | regulation of lipoprotein metabolic process (GO:0050746) | 3.21120977 |
| 27 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.19610187 |
| 28 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.19610187 |
| 29 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.19010039 |
| 30 | negative regulation of platelet activation (GO:0010544) | 3.14221605 |
| 31 | amine catabolic process (GO:0009310) | 3.12347647 |
| 32 | cellular biogenic amine catabolic process (GO:0042402) | 3.12347647 |
| 33 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.12332338 |
| 34 | diol metabolic process (GO:0034311) | 3.04382424 |
| 35 | adaptation of signaling pathway (GO:0023058) | 3.03365902 |
| 36 | sphingoid metabolic process (GO:0046519) | 3.02344521 |
| 37 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.01852613 |
| 38 | muscle filament sliding (GO:0030049) | 3.01698501 |
| 39 | actin-myosin filament sliding (GO:0033275) | 3.01698501 |
| 40 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.97053177 |
| 41 | neuronal action potential propagation (GO:0019227) | 2.93279848 |
| 42 | sphingosine metabolic process (GO:0006670) | 2.92233286 |
| 43 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.91601996 |
| 44 | regulation of cilium movement (GO:0003352) | 2.91204928 |
| 45 | phospholipid homeostasis (GO:0055091) | 2.90668613 |
| 46 | cytidine metabolic process (GO:0046087) | 2.86311623 |
| 47 | cytidine catabolic process (GO:0006216) | 2.86311623 |
| 48 | cytidine deamination (GO:0009972) | 2.86311623 |
| 49 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.85131081 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.83678529 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 2.83678529 |
| 52 | regulation of meiosis I (GO:0060631) | 2.82160612 |
| 53 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.81739882 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80842885 |
| 55 | DNA deamination (GO:0045006) | 2.80718735 |
| 56 | low-density lipoprotein particle remodeling (GO:0034374) | 2.80121915 |
| 57 | skeletal muscle contraction (GO:0003009) | 2.79267497 |
| 58 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.78452493 |
| 59 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.78195624 |
| 60 | detection of light stimulus involved in visual perception (GO:0050908) | 2.78195624 |
| 61 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.76457390 |
| 62 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.75891070 |
| 63 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75290319 |
| 64 | negative regulation of norepinephrine secretion (GO:0010700) | 2.74978159 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.74519657 |
| 66 | regulation of relaxation of muscle (GO:1901077) | 2.68201928 |
| 67 | regulation of hexokinase activity (GO:1903299) | 2.67277542 |
| 68 | regulation of glucokinase activity (GO:0033131) | 2.67277542 |
| 69 | blood coagulation, intrinsic pathway (GO:0007597) | 2.65955426 |
| 70 | skeletal muscle tissue regeneration (GO:0043403) | 2.63729156 |
| 71 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.60984950 |
| 72 | piRNA metabolic process (GO:0034587) | 2.60326830 |
| 73 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.59415288 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59152669 |
| 75 | rhodopsin mediated signaling pathway (GO:0016056) | 2.56551288 |
| 76 | reverse cholesterol transport (GO:0043691) | 2.56265843 |
| 77 | multicellular organism reproduction (GO:0032504) | 2.56157124 |
| 78 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.55482874 |
| 79 | actin-mediated cell contraction (GO:0070252) | 2.54661217 |
| 80 | plasma membrane fusion (GO:0045026) | 2.53550404 |
| 81 | relaxation of muscle (GO:0090075) | 2.51674158 |
| 82 | DNA methylation involved in gamete generation (GO:0043046) | 2.51029097 |
| 83 | aromatic amino acid family catabolic process (GO:0009074) | 2.50965432 |
| 84 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.50906338 |
| 85 | xenobiotic catabolic process (GO:0042178) | 2.49928824 |
| 86 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.49001150 |
| 87 | negative regulation of muscle contraction (GO:0045932) | 2.48816586 |
| 88 | glycerophospholipid catabolic process (GO:0046475) | 2.46920066 |
| 89 | regulation of sarcomere organization (GO:0060297) | 2.46862906 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 2.46597946 |
| 91 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.46589414 |
| 92 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.45297192 |
| 93 | negative regulation of cation channel activity (GO:2001258) | 2.44821551 |
| 94 | purinergic receptor signaling pathway (GO:0035587) | 2.43117352 |
| 95 | negative regulation of heart contraction (GO:0045822) | 2.42764275 |
| 96 | axoneme assembly (GO:0035082) | 2.41894334 |
| 97 | synaptic transmission, cholinergic (GO:0007271) | 2.40429514 |
| 98 | male meiosis (GO:0007140) | 2.39735465 |
| 99 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.38673931 |
| 100 | regulation of appetite (GO:0032098) | 2.38631199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50972328 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.16389054 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69311819 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.66839154 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.64703144 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.49231480 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.41807500 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40537933 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33005006 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12033774 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.07089664 |
| 12 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.95931513 |
| 13 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93413857 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91322480 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85970492 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83494903 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75690028 |
| 18 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.71582818 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.67566590 |
| 20 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64234285 |
| 21 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64121244 |
| 22 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63952714 |
| 23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63712788 |
| 24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62081664 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61555410 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59153283 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58918213 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57424168 |
| 29 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.51844978 |
| 30 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.51844978 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51359717 |
| 32 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50604587 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50282295 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48471155 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45993567 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45406423 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44560501 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40415560 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39594567 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39526341 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39058999 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39048515 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38870540 |
| 44 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.37691740 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37010144 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36172204 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33335613 |
| 48 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33227817 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33122740 |
| 50 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31827169 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31191633 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30590598 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30396101 |
| 54 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.29102062 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25345390 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24849040 |
| 57 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.24131292 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23231204 |
| 59 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22898691 |
| 60 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.22831792 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22606815 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22606815 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22005662 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21126274 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21126274 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21118311 |
| 67 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20734952 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20733584 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18935228 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18211078 |
| 71 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17616672 |
| 72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16732652 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16487854 |
| 74 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.15400817 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15277714 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15277714 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14216734 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14086131 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11472535 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09525014 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07885452 |
| 82 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07875799 |
| 83 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07326596 |
| 84 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07283752 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06583517 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06583517 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04997594 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04382411 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03955779 |
| 90 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03737415 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03695456 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02991902 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02500035 |
| 94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01862965 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00637680 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99777474 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99197961 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98806027 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98406492 |
| 100 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96873478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.72888577 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.46863947 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.38183187 |
| 4 | MP0003136_yellow_coat_color | 3.02530814 |
| 5 | MP0004084_abnormal_cardiac_muscle | 2.98094727 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 2.90545875 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.70361734 |
| 8 | MP0008872_abnormal_physiological_respon | 2.42795739 |
| 9 | MP0008004_abnormal_stomach_pH | 2.36680158 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.16500846 |
| 11 | MP0000749_muscle_degeneration | 2.15627528 |
| 12 | MP0002736_abnormal_nociception_after | 2.14697540 |
| 13 | MP0004130_abnormal_muscle_cell | 2.11910310 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.09863185 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.04013914 |
| 16 | MP0005646_abnormal_pituitary_gland | 1.91900689 |
| 17 | MP0004147_increased_porphyrin_level | 1.91350885 |
| 18 | MP0002332_abnormal_exercise_endurance | 1.86623701 |
| 19 | MP0000230_abnormal_systemic_arterial | 1.85608034 |
| 20 | MP0002102_abnormal_ear_morphology | 1.84010362 |
| 21 | MP0003724_increased_susceptibility_to | 1.83860943 |
| 22 | MP0005410_abnormal_fertilization | 1.82743203 |
| 23 | MP0005620_abnormal_muscle_contractility | 1.81633969 |
| 24 | MP0004484_altered_response_of | 1.81386672 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.79348956 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.78337703 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.76111742 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.68512748 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.65169833 |
| 30 | MP0005171_absent_coat_pigmentation | 1.63287089 |
| 31 | MP0003195_calcinosis | 1.61470193 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.61366027 |
| 33 | MP0003879_abnormal_hair_cell | 1.59997230 |
| 34 | MP0004043_abnormal_pH_regulation | 1.57910250 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.53976489 |
| 36 | MP0004142_abnormal_muscle_tone | 1.53395049 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.52123663 |
| 38 | MP0003045_fibrosis | 1.51347745 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.41529395 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.37812711 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.37807302 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.35716271 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.35087251 |
| 44 | MP0002106_abnormal_muscle_physiology | 1.29932100 |
| 45 | MP0001984_abnormal_olfaction | 1.27990482 |
| 46 | MP0009046_muscle_twitch | 1.27851360 |
| 47 | MP0004510_myositis | 1.23555043 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.23464103 |
| 49 | MP0004085_abnormal_heartbeat | 1.17811858 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.16972773 |
| 51 | MP0005083_abnormal_biliary_tract | 1.14579263 |
| 52 | MP0005671_abnormal_response_to | 1.12317005 |
| 53 | MP0001970_abnormal_pain_threshold | 1.12174427 |
| 54 | MP0003638_abnormal_response/metabolism_ | 1.10596500 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.10104291 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.08313394 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.06773715 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06568959 |
| 59 | MP0009745_abnormal_behavioral_response | 1.03250611 |
| 60 | MP0009764_decreased_sensitivity_to | 1.02709859 |
| 61 | MP0003011_delayed_dark_adaptation | 1.01750807 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.00943791 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.00943791 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.00683271 |
| 65 | MP0000427_abnormal_hair_cycle | 0.99276038 |
| 66 | MP0005174_abnormal_tail_pigmentation | 0.97578985 |
| 67 | MP0003137_abnormal_impulse_conducting | 0.96486896 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.94582221 |
| 69 | MP0005253_abnormal_eye_physiology | 0.94248803 |
| 70 | MP0005369_muscle_phenotype | 0.92380944 |
| 71 | MP0004885_abnormal_endolymph | 0.91920662 |
| 72 | MP0000343_altered_response_to | 0.90782124 |
| 73 | MP0005670_abnormal_white_adipose | 0.89282598 |
| 74 | MP0002272_abnormal_nervous_system | 0.89194265 |
| 75 | MP0001486_abnormal_startle_reflex | 0.88500410 |
| 76 | MP0005266_abnormal_metabolism | 0.83944362 |
| 77 | MP0000383_abnormal_hair_follicle | 0.83493269 |
| 78 | MP0003880_abnormal_central_pattern | 0.83041933 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.79338993 |
| 80 | MP0002735_abnormal_chemical_nociception | 0.77576970 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.77210444 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.76368932 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.76106809 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.76054419 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.75712000 |
| 86 | MP0003787_abnormal_imprinting | 0.74617082 |
| 87 | MP0005535_abnormal_body_temperature | 0.73883734 |
| 88 | MP0002067_abnormal_sensory_capabilities | 0.71676438 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.71422333 |
| 90 | MP0005448_abnormal_energy_balance | 0.70735299 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 0.70363998 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.70322517 |
| 93 | MP0003718_maternal_effect | 0.70089506 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.69270285 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.67547006 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.67447294 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.67122634 |
| 98 | MP0001529_abnormal_vocalization | 0.66896070 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.65555384 |
| 100 | MP0002064_seizures | 0.65095103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 5.49101343 |
| 2 | Petechiae (HP:0000967) | 4.92919409 |
| 3 | Menorrhagia (HP:0000132) | 4.64711597 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.41376081 |
| 5 | Increased mean platelet volume (HP:0011877) | 4.36713491 |
| 6 | Nemaline bodies (HP:0003798) | 4.08078037 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.03393704 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.94876757 |
| 9 | Purpura (HP:0000979) | 3.75493387 |
| 10 | Nonprogressive disorder (HP:0003680) | 3.74032053 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.72734732 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 3.51175599 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.42520228 |
| 14 | Epistaxis (HP:0000421) | 3.33738945 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.30120941 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 3.24208855 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 3.01199166 |
| 18 | Decreased central vision (HP:0007663) | 3.00509383 |
| 19 | Pancreatic cysts (HP:0001737) | 3.00035313 |
| 20 | Dyschromatopsia (HP:0007641) | 2.97559987 |
| 21 | Abnormal pupillary function (HP:0007686) | 2.84491245 |
| 22 | Gingival bleeding (HP:0000225) | 2.75760783 |
| 23 | Stomatitis (HP:0010280) | 2.69660690 |
| 24 | Renal cortical cysts (HP:0000803) | 2.63585186 |
| 25 | Poikilocytosis (HP:0004447) | 2.62415109 |
| 26 | Acanthocytosis (HP:0001927) | 2.60697323 |
| 27 | Paralysis (HP:0003470) | 2.51223861 |
| 28 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45931099 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.45931099 |
| 30 | Hyperalaninemia (HP:0003348) | 2.45931099 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.38693629 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38353041 |
| 33 | Pancreatic fibrosis (HP:0100732) | 2.34355859 |
| 34 | Distal arthrogryposis (HP:0005684) | 2.33896264 |
| 35 | Myoglobinuria (HP:0002913) | 2.33082868 |
| 36 | Rimmed vacuoles (HP:0003805) | 2.31524666 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 2.25825444 |
| 38 | Areflexia of lower limbs (HP:0002522) | 2.21280472 |
| 39 | Muscle fiber splitting (HP:0003555) | 2.19014359 |
| 40 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17931395 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 2.16383132 |
| 42 | True hermaphroditism (HP:0010459) | 2.15995863 |
| 43 | Inability to walk (HP:0002540) | 2.14328701 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.12061035 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.11432632 |
| 46 | Abnormality of midbrain morphology (HP:0002418) | 2.11432632 |
| 47 | Absent/shortened dynein arms (HP:0200106) | 2.10717611 |
| 48 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.10717611 |
| 49 | Type II lissencephaly (HP:0007260) | 2.08504923 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.06891074 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.05803774 |
| 52 | Acute encephalopathy (HP:0006846) | 2.02861534 |
| 53 | Nephronophthisis (HP:0000090) | 2.00453196 |
| 54 | Thyroid-stimulating hormone excess (HP:0002925) | 2.00065401 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 1.99650104 |
| 56 | Type 2 muscle fiber atrophy (HP:0003554) | 1.99036317 |
| 57 | Febrile seizures (HP:0002373) | 1.97015165 |
| 58 | Abnormal ciliary motility (HP:0012262) | 1.96972843 |
| 59 | Bundle branch block (HP:0011710) | 1.96868092 |
| 60 | Hyperventilation (HP:0002883) | 1.96694597 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 1.95390256 |
| 62 | Tinnitus (HP:0000360) | 1.94656229 |
| 63 | Abnormal drinking behavior (HP:0030082) | 1.94630244 |
| 64 | Polydipsia (HP:0001959) | 1.94630244 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 1.93949404 |
| 66 | Abnormality of lateral ventricle (HP:0030047) | 1.93556500 |
| 67 | Hypoproteinemia (HP:0003075) | 1.90423650 |
| 68 | Abnormal platelet function (HP:0011869) | 1.90391838 |
| 69 | Impaired platelet aggregation (HP:0003540) | 1.90391838 |
| 70 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87694173 |
| 71 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87580616 |
| 72 | Mitochondrial inheritance (HP:0001427) | 1.87269439 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 1.87135395 |
| 74 | Hyperkalemia (HP:0002153) | 1.82973302 |
| 75 | Ventricular fibrillation (HP:0001663) | 1.82923600 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79484131 |
| 77 | Focal motor seizures (HP:0011153) | 1.77597106 |
| 78 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77016574 |
| 79 | Hypoplasia of the fovea (HP:0007750) | 1.77016574 |
| 80 | Hepatic necrosis (HP:0002605) | 1.76062930 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 1.75058952 |
| 82 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.72886832 |
| 83 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.72886832 |
| 84 | Fair hair (HP:0002286) | 1.71656681 |
| 85 | Progressive inability to walk (HP:0002505) | 1.71196900 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 1.70334976 |
| 87 | Tongue fasciculations (HP:0001308) | 1.69095950 |
| 88 | Amelogenesis imperfecta (HP:0000705) | 1.68244405 |
| 89 | Rhabdomyolysis (HP:0003201) | 1.68047830 |
| 90 | Abnormality of the neuromuscular junction (HP:0003398) | 1.66806229 |
| 91 | Fatigable weakness (HP:0003473) | 1.66806229 |
| 92 | Increased CSF lactate (HP:0002490) | 1.64787895 |
| 93 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.64570071 |
| 94 | Absent phalangeal crease (HP:0006109) | 1.64409384 |
| 95 | Abnormal finger flexion creases (HP:0006143) | 1.62528777 |
| 96 | Keratoconus (HP:0000563) | 1.62232937 |
| 97 | Increased corneal curvature (HP:0100692) | 1.62232937 |
| 98 | Optic nerve hypoplasia (HP:0000609) | 1.61718863 |
| 99 | Lissencephaly (HP:0001339) | 1.61247977 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.61093969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.37883179 |
| 2 | FRK | 4.01758679 |
| 3 | MST4 | 3.62762681 |
| 4 | TAOK3 | 3.32069431 |
| 5 | PHKG2 | 3.11345373 |
| 6 | PHKG1 | 3.11345373 |
| 7 | PIK3CG | 2.44716848 |
| 8 | PINK1 | 2.43861880 |
| 9 | ADRBK2 | 2.35203257 |
| 10 | BMPR1B | 2.32204929 |
| 11 | ACVR1B | 2.29788471 |
| 12 | ZAK | 2.26466631 |
| 13 | MAP4K2 | 2.10124162 |
| 14 | PTK2B | 2.02073800 |
| 15 | STK38L | 1.70558708 |
| 16 | MYLK | 1.69064874 |
| 17 | NUAK1 | 1.64159828 |
| 18 | TEC | 1.58575045 |
| 19 | TNIK | 1.54138965 |
| 20 | MAPKAPK3 | 1.53792188 |
| 21 | STK3 | 1.47519869 |
| 22 | GRK5 | 1.42655027 |
| 23 | WNK3 | 1.39728909 |
| 24 | GRK1 | 1.39578242 |
| 25 | DAPK2 | 1.39157742 |
| 26 | PLK2 | 1.34529494 |
| 27 | TLK1 | 1.34335112 |
| 28 | EIF2AK1 | 1.30185836 |
| 29 | LATS1 | 1.24627827 |
| 30 | BMX | 1.17898060 |
| 31 | RIPK4 | 1.15309867 |
| 32 | MAPK13 | 1.14078114 |
| 33 | CCNB1 | 1.10470372 |
| 34 | TXK | 1.07670319 |
| 35 | BTK | 1.04773803 |
| 36 | ADRBK1 | 1.04670715 |
| 37 | SYK | 1.04308760 |
| 38 | MARK3 | 0.97224528 |
| 39 | NLK | 0.94490001 |
| 40 | TNK2 | 0.91357771 |
| 41 | MAP3K4 | 0.91162516 |
| 42 | BRSK2 | 0.86825701 |
| 43 | PAK3 | 0.86374475 |
| 44 | PKN1 | 0.82117405 |
| 45 | FER | 0.80127456 |
| 46 | INSRR | 0.79558044 |
| 47 | MUSK | 0.79453206 |
| 48 | IKBKB | 0.78724845 |
| 49 | PRKAA2 | 0.77355764 |
| 50 | OXSR1 | 0.75821033 |
| 51 | PRKCE | 0.75794931 |
| 52 | GRK6 | 0.75193534 |
| 53 | TRIM28 | 0.75164704 |
| 54 | ERBB3 | 0.73247508 |
| 55 | VRK1 | 0.71708171 |
| 56 | PNCK | 0.71253211 |
| 57 | TRPM7 | 0.68755008 |
| 58 | MAPK12 | 0.66400849 |
| 59 | MAP2K6 | 0.64833297 |
| 60 | PRKG1 | 0.60987461 |
| 61 | MAP3K7 | 0.60294838 |
| 62 | PLK3 | 0.58629799 |
| 63 | WNK4 | 0.56396054 |
| 64 | CSF1R | 0.56096801 |
| 65 | CSNK1G1 | 0.55324735 |
| 66 | STK39 | 0.54876872 |
| 67 | CDK8 | 0.54842397 |
| 68 | ILK | 0.53447141 |
| 69 | CAMK2A | 0.53182682 |
| 70 | GRK7 | 0.52591661 |
| 71 | CSNK1G3 | 0.50642483 |
| 72 | PRKACA | 0.49696249 |
| 73 | PIK3CA | 0.48520741 |
| 74 | MAP2K1 | 0.46591021 |
| 75 | EPHA3 | 0.46403118 |
| 76 | CSNK1G2 | 0.45735624 |
| 77 | PRKCQ | 0.45505481 |
| 78 | MAP2K7 | 0.45195769 |
| 79 | FGR | 0.45041384 |
| 80 | MATK | 0.44164195 |
| 81 | LYN | 0.44004404 |
| 82 | BCKDK | 0.43098656 |
| 83 | PRKCG | 0.41577014 |
| 84 | PRKD1 | 0.40948401 |
| 85 | BMPR2 | 0.39855176 |
| 86 | TIE1 | 0.37358189 |
| 87 | HCK | 0.36290717 |
| 88 | CAMK1 | 0.36274221 |
| 89 | PLK4 | 0.36116225 |
| 90 | PRKACG | 0.35617334 |
| 91 | CASK | 0.34997274 |
| 92 | MARK1 | 0.34290008 |
| 93 | SGK2 | 0.33676213 |
| 94 | MAP2K4 | 0.33323556 |
| 95 | ITK | 0.33129948 |
| 96 | DAPK3 | 0.32201389 |
| 97 | PRKCA | 0.30632050 |
| 98 | CSNK1D | 0.28719273 |
| 99 | PRKAA1 | 0.28229142 |
| 100 | TTN | 0.26494678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40516250 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.80733324 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 2.79586485 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.46218204 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.32095611 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.24994021 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.16574835 |
| 8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.12264713 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.06169201 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79824748 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.77857816 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75868661 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73612390 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65323705 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.63567172 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62507516 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58298128 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57957881 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57214729 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49222353 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49183566 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.46854014 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.46462624 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.43927976 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41861247 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40966665 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37552271 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32683544 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32060740 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.30972463 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30380071 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.24303588 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23633105 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.22360003 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20799064 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18826730 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17676499 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17475664 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15987924 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14181313 |
| 41 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10989013 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07885821 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06999713 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.06356403 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06163651 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02678944 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02336676 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00581620 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96273639 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92837665 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91872214 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91560609 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91016649 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90837720 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89539214 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88220343 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.87138545 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.85682332 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84523406 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84501961 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84221172 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.83465920 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83204913 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.82193130 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81462081 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80649879 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79351187 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.77446528 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75409248 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74686068 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73289608 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72580584 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72315469 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70893778 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67783558 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.67002251 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66332541 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65359654 |
| 79 | Purine metabolism_Homo sapiens_hsa00230 | 0.63721944 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63485428 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63003533 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59936288 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.58473012 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56802752 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56316264 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55264665 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53576076 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52710821 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51515385 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51373798 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50441470 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49856683 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47910414 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46413841 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45180758 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40155206 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39876335 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38825631 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38471556 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38356024 |

